{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T15:51:34Z","timestamp":1791215494420,"version":"4.1.0"},"reference-count":28,"publisher":"American Medical Association (AMA)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Pediatr"],"published-print":{"date-parts":[[2026,10,1]]},"abstract":"\n Importance<\/jats:title>\n National organizations recommend antiviral treatment for hospitalized children with influenza; however, use in this setting has recently declined. Studies of oseltamivir effectiveness in children are limited by misclassification bias, unknown symptom onset date, and incomplete capture of antiviral use prior to admission.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To assess the association between oseltamivir receipt and intensive care unit (ICU) admission and hospital length of stay (LOS) among pediatric influenza-associated hospitalizations.<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n This cohort study used data that were obtained from the Influenza Hospitalization Surveillance Network (FluSurv-NET), which conducts US population-based surveillance for laboratory-confirmed influenza hospitalizations for all ages across 13 states. The study data include seasons 2014 to 2015 through 2022 to 2023, excluding 2020 to 2021. Participants included children aged younger than 18 years who were hospitalized with laboratory-confirmed influenza and for whom a respiratory symptom onset date was available. These data were analyzed from October 2024 through May 2026.<\/jats:p>\n <\/jats:sec>\n \n Exposures<\/jats:title>\n Oseltamivir receipt as a time-dependent exposure.<\/jats:p>\n <\/jats:sec>\n \n Main Outcome(s) and Measure(s)<\/jats:title>\n The primary outcome was time from symptom onset to ICU admission. Secondary outcome was time from admission to discharge (LOS). Adjusted Cox proportional hazard models (aHR) with oseltamivir receipt as a time-dependent exposure were used.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n After exclusions, 6044 influenza cases were included in the primary ICU analysis, of whom 4240 (70.2%) received oseltamivir, and 7103 cases were included in the secondary LOS analysis, of whom 5746 (80.9%) received oseltamivir. In the ICU analysis, the median (IQR) age was 3 (1-7) years, 3382 (56%) were male and 3721 (44%) were female, and 2937 (49%) had 1 or more medical comorbidity\u2014the most common of which was asthma in 1547 children (26%). In adjusted models, compared with untreated children, oseltamivir treatment reduced the hazard of ICU admission (aHR, 0.69; 95% CI, 0.60-0.80) and shortened LOS (analyzed as hazard of hospital discharge; aHR, 1.13; 95% CI, 1.06-1.21).<\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n In this cohort of children hospitalized with influenza, oseltamivir treatment was significantly associated with a reduced risk of ICU admission by 31% and decreased hospital LOS. These findings demonstrate the benefits of oseltamivir receipt and support current national recommendations for oseltamivir treatment as soon as possible in children hospitalized with suspected or laboratory-confirmed influenza.<\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamapediatrics.2026.3376","type":"journal-article","created":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T15:30:27Z","timestamp":1786375827000},"page":"1116","source":"Crossref","is-referenced-by-count":1,"title":["Effectiveness of Oseltamivir in Hospitalized Children With Laboratory-Confirmed Influenza, 2014-2023"],"prefix":"10.1001","volume":"180","author":[{"given":"Kacie","family":"Rytlewski","sequence":"first","affiliation":[{"name":"Department of Pediatrics, University of Colorado School of Medicine and Children\u2019s Hospital Colorado, Aurora"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Dunn","sequence":"additional","affiliation":[{"name":"Adult and Child Center for Outcomes Research and Delivery Science, University of Colorado School of Medicine and Children\u2019s Hospital Colorado, Aurora"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alissa","family":"O\u2019Halloran","sequence":"additional","affiliation":[{"name":"Influenza Division, US Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Habeck","sequence":"additional","affiliation":[{"name":"Influenza Division, US Centers for Disease Control and Prevention, Atlanta, Georgia"},{"name":"Goldbelt Professional Services, Chesapeake, Virginia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaac","family":"Armistead","sequence":"additional","affiliation":[{"name":"Colorado Department of Public Health and Environment, Denver"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nisha B.","family":"Alden","sequence":"additional","affiliation":[{"name":"Colorado Department of Public Health and Environment, Denver"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darpun","family":"Sachdev","sequence":"additional","affiliation":[{"name":"California Department of Public Health, Richmond"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pam","family":"Daily Kirley","sequence":"additional","affiliation":[{"name":"California Emerging Infections Program, Oakland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Meek","sequence":"additional","affiliation":[{"name":"Connecticut Emerging Infections Program, Yale School of Public Health, New Haven"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly","family":"Yousey-Hindes","sequence":"additional","affiliation":[{"name":"Connecticut Emerging Infections Program, Yale School of Public Health, New Haven"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Kamidani","sequence":"additional","affiliation":[{"name":"Emory University School of Medicine and Children\u2019s Healthcare of Atlanta, Atlanta, Georgia"},{"name":"Children\u2019s Healthcare of Atlanta, Atlanta, Georgia"},{"name":"Georgia Emerging Infections Program, Atlanta"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle P.","family":"Openo","sequence":"additional","affiliation":[{"name":"Georgia Emerging Infections Program, Atlanta"},{"name":"Division of Infectious Diseases, Emory University School of Medicine, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia A.","family":"Ryan","sequence":"additional","affiliation":[{"name":"Maryland Department of Health, Baltimore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maya","family":"Monroe","sequence":"additional","affiliation":[{"name":"Maryland Department of Health, Baltimore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sue","family":"Kim","sequence":"additional","affiliation":[{"name":"Michigan Department of Health and Human Services, Lansing"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Urlaub","sequence":"additional","affiliation":[{"name":"Michigan Department of Health and Human Services, Lansing"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Lynfield","sequence":"additional","affiliation":[{"name":"Minnesota Department of Health, St Paul"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"McMahon","sequence":"additional","affiliation":[{"name":"Minnesota Department of Health, St Paul"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chad B.","family":"Smelser","sequence":"additional","affiliation":[{"name":"New Mexico Department of Health, Santa Fe"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yomei","family":"Shaw","sequence":"additional","affiliation":[{"name":"New Mexico Department of Health, Santa Fe"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grant","family":"Barney","sequence":"additional","affiliation":[{"name":"New York State Department of Health, Albany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jemma V.","family":"Rowlands","sequence":"additional","affiliation":[{"name":"New York State Department of Health, Albany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenda","family":"Tesini","sequence":"additional","affiliation":[{"name":"University of Rochester Medical Center, Rochester, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Felsen","sequence":"additional","affiliation":[{"name":"University of Rochester Medical Center, Rochester, New York"},{"name":"New York Emerging Infections Program, Albany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krista","family":"Lung","sequence":"additional","affiliation":[{"name":"Ohio Department of Health, Columbus"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Sutton","sequence":"additional","affiliation":[{"name":"Public Health Division, Oregon Health Authority, Portland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann","family":"Thomas","sequence":"additional","affiliation":[{"name":"Public Health Division, Oregon Health Authority, Portland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Keipp","family":"Talbot","sequence":"additional","affiliation":[{"name":"Vanderbilt University Medical Center, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Schaffner","sequence":"additional","affiliation":[{"name":"Vanderbilt University Medical Center, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"George","sequence":"additional","affiliation":[{"name":"Salt Lake County Health Department, Salt Lake City, Utah"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holly","family":"Staten","sequence":"additional","affiliation":[{"name":"Salt Lake County Health Department, Salt Lake City, Utah"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica R.","family":"Cataldi","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Colorado School of Medicine and Children\u2019s Hospital Colorado, Aurora"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel R.","family":"Dominguez","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Colorado School of Medicine and Children\u2019s Hospital Colorado, Aurora"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine H.","family":"Bozio","sequence":"additional","affiliation":[{"name":"Influenza Division, US Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suchitra","family":"Rao","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Colorado School of Medicine and Children\u2019s Hospital Colorado, Aurora"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"key":"poi260047r1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002744.pub3","article-title":"Neuraminidase inhibitors for preventing and treating influenza in children.","volume":"1","author":"Wang","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"poi260047r2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008965.pub4","article-title":"Neuraminidase inhibitors for preventing and treating influenza in adults and children.","volume":"2014","author":"Jefferson","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"poi260047r3","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/S1473-3099(13)70267-6","article-title":"Efficacy of oseltamivir treatment started within 5 days of symptom onset to reduce influenza illness duration and virus shedding in an urban setting in Bangladesh: a randomised placebo-controlled trial.","volume":"14","author":"Fry","year":"2014","journal-title":"Lancet Infect Dis"},{"issue":"11","key":"poi260047r4","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1097\/INF.0b013e318232ede9","article-title":"Oseltamivir shortens hospital stays of critically ill children hospitalized with seasonal influenza: a retrospective cohort study.","volume":"30","author":"Coffin","year":"2011","journal-title":"Pediatr Infect Dis J"},{"issue":"4","key":"poi260047r5","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2021-050417","article-title":"Influenza antiviral treatment and length of stay.","volume":"148","author":"Campbell","year":"2021","journal-title":"Pediatrics"},{"issue":"7","key":"poi260047r6","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1017\/S0950268818000663","article-title":"Effectiveness of antiviral treatment in preventing death in severe hospitalised influenza cases over six seasons.","volume":"146","author":"Dom\u00ednguez","year":"2018","journal-title":"Epidemiol Infect"},{"issue":"11","key":"poi260047r7","doi-asserted-by":"publisher","DOI":"10.1001\/jamapediatrics.2022.3261","article-title":"Association of early oseltamivir with improved outcomes in hospitalized children with influenza, 2007-2020.","volume":"176","author":"Walsh","year":"2022","journal-title":"JAMA Pediatr"},{"issue":"6","key":"poi260047r9","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/cid\/ciy866","article-title":"Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 update on diagnosis, treatment, chemoprophylaxis, and institutional outbreak management of seasonal influenza.","volume":"68","author":"Uyeki","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"4","key":"poi260047r10","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2024-068507","article-title":"Recommendations for Prevention and Control of Influenza in Children, 2024-2025: Policy Statement.","volume":"154","author":"Committee on Infectious Diseases","year":"2024","journal-title":"Pediatrics"},{"issue":"6","key":"poi260047r11","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1097\/PCC.0b013e318260114e","article-title":"Risk factors for mechanical ventilation in U.S. children hospitalized with seasonal influenza and 2009 pandemic influenza A*.","volume":"13","author":"Eriksson","year":"2012","journal-title":"Pediatr Crit Care Med"},{"issue":"3","key":"poi260047r12","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2018-2608","article-title":"Early use of anti-influenza medications in hospitalized children with tracheostomy.","volume":"143","author":"Miyakawa","year":"2019","journal-title":"Pediatrics"},{"issue":"1","key":"poi260047r13","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1001\/jamainternmed.2023.0699","article-title":"Evaluation of oseltamivir used to prevent hospitalization in outpatients with influenza: a systematic review and meta-analysis.","volume":"184","author":"Hanula","year":"2024","journal-title":"JAMA Intern Med"},{"issue":"10","key":"poi260047r15","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.18553\/jmcp.2025.31.10.1051","article-title":"Associations of oseltamivir with neuropsychiatric and behavioral adverse events: a systematic review and meta-analysis.","volume":"31","author":"Jeong","year":"2025","journal-title":"J Manag Care Spec Pharm"},{"issue":"10","key":"poi260047r16","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1001\/jamaneurol.2025.1995","article-title":"Influenza with and without oseltamivir treatment and neuropsychiatric events among children and adolescents.","volume":"82","author":"Antoon","year":"2025","journal-title":"JAMA Neurol"},{"issue":"45","key":"poi260047r17","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.15585\/mmwr.mm7345a2","article-title":"Underutilization of influenza antiviral treatment among children and adolescents at higher risk for influenza-associated complications\u2014United States, 2023-2024.","volume":"73","author":"Frutos","year":"2024","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"poi260047r19","article-title":"Antiviral use among children hospitalized with laboratory-confirmed influenza illness: a prospective, multicenter surveillance study.","author":"Antoon","year":"2024","journal-title":"Clin Infect Dis"},{"issue":"5","key":"poi260047r20","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2024-069111","article-title":"Variability of clinician recommendations for oseltamivir in children hospitalized with influenza.","volume":"155","author":"Bassett","year":"2025","journal-title":"Pediatrics"},{"issue":"3","key":"poi260047r21","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.1323","article-title":"Respiratory and nonrespiratory diagnoses associated with influenza in hospitalized adults.","volume":"3","author":"Chow","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"10","key":"poi260047r22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0040296","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.","volume":"4","author":"von Elm","year":"2007","journal-title":"PLoS Med"},{"issue":"10","key":"poi260047r23","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1093\/cid\/cix1040","article-title":"Efficacy and safety of oseltamivir in children: systematic review and individual patient data meta-analysis of randomized controlled trials.","volume":"66","author":"Malosh","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"8","key":"poi260047r24","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1086\/656408","article-title":"Early oseltamivir treatment of influenza in children 1-3 years of age: a randomized controlled trial.","volume":"51","author":"Heinonen","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"6","key":"poi260047r25","doi-asserted-by":"publisher","first-page":"e1539","DOI":"10.1542\/peds.2013-2149","article-title":"Neuraminidase inhibitors for critically ill children with influenza.","volume":"132","author":"Louie","year":"2013","journal-title":"Pediatrics"},{"issue":"2","key":"poi260047r26","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1001\/jamapediatrics.2023.5731","article-title":"Misclassification of both influenza infection and oseltamivir exposure status in administrative data.","volume":"178","author":"Bassett","year":"2024","journal-title":"JAMA Pediatr"},{"key":"poi260047r27","doi-asserted-by":"publisher","first-page":"b5087","DOI":"10.1136\/bmj.b5087","article-title":"Problem of immortal time bias in cohort studies: example using statins for preventing progression of diabetes.","volume":"340","author":"L\u00e9vesque","year":"2010","journal-title":"BMJ"},{"issue":"4","key":"poi260047r28","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1093\/aje\/kwm324","article-title":"Immortal time bias in pharmaco-epidemiology.","volume":"167","author":"Suissa","year":"2008","journal-title":"Am J Epidemiol"},{"key":"poi260047r14"},{"key":"poi260047r8","unstructured":"US Centers for Disease Control and Prevention. Influenza antiviral medications: summary for clinicians. Accessed July 6, 2026. https:\/\/www.cdc.gov\/flu\/hcp\/antivirals\/summary-clinicians.html"},{"key":"poi260047r18","unstructured":"US Centers for Disease Control and Prevention. FluView Interactive. Accessed July 6, 2026. https:\/\/gis.cdc.gov\/grasp\/fluview\/FluHospChars.html."}],"container-title":["JAMA Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamapediatrics\/articlepdf\/2852671\/jamapediatrics_rytlewski_2026_oi_260047_1790892866.18463.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T15:00:42Z","timestamp":1791212442000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamapediatrics\/fullarticle\/2852671"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,1]]},"references-count":28,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamapediatrics.2026.3376","relation":{},"ISSN":["2168-6203"],"issn-type":[{"value":"2168-6203","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10,1]]}}}